Spectral Medical Inc. (EDTXF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Spectral Medical Inc. (EDTXF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.605

Daily Change: +$0.00412 / 0.68%

Range: $0.601 - $0.605

Market Cap: $172,581,312

Volume: 15,300

Performance Metrics

1 Week: -4.16%

1 Month: 1.12%

3 Months: 20.96%

6 Months: 62.04%

1 Year: 58.21%

YTD: 58.62%

Company Details

Employees: 29

Sector: Health technology

Industry: Medical specialties

Country: Canada

Details

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Selected stocks

Hamamatsu Photonics (HPHTF)

Hamamatsu Photonics (HPHTY)

GameOn Entertainment Technologies Inc. (GMETF)